<DOC>
	<DOCNO>NCT02287532</DOCNO>
	<brief_summary>The aim TELESAGE study demonstrate 1. superiority follow DIABEO system ( software alone ) versus usual follow term improvement HbA1c 1 year DM1 DM2 patient treat basal-bolus insulin regimen . 2. superiority follow DIABEO system ( software + telemonitoring ) compare usual follow term improvement HbA1c 1 year DM1 DM2 patient treat basal-bolus insulin regimen . The DIABEO software alone electronic diary system incorporate immediate automatic aid calculate insulin dose accord prescription give doctor , data processing , automate analysis message secure internet data transfer system . The DIABEO software add paramedical telemonitoring electronic diary combine remote paramedical monitoring data ( telemeonitoring )</brief_summary>
	<brief_title>Evaluation DIABEO System Poorly Controlled DM1 DM2 Patients Treated With Basal-bolus Insulin Regimen</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 type 2 diabetic patient Performing autoglycaemic control ( least 2 glycemias day ) Treated insulin basalbolus regimen least 1 year use method administration least 3 month ( insulin pen pump ) Who Apple® Androïde® Smartphone compatible , intend acquire one participation study Whose HbA1c date less 1 month 3 month ≥ 8 % Who able understand follow study protocol Who give sign consent take part study Subject affiliate French National Health Insurance fund benefit insurance Age &lt; 18 year old Patients use DIABEO system within 6 month inclusion Participation clinical study within 6 month , except Meos ( télédiab 3 ) study participation period 6 month Patients pregnant wish become pregnant study . Patients treat human insulin A patient prescreening register set centre establish reason DM1/DM2 patient treat basalbolus insulin regimen take part study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>